Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anaplastic Thyroid Carcinomas”

104 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 104 results

Testing effectiveness (Phase 2)Study completedNCT02114658
What this trial is testing

Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients

Who this might be right for
Thyroid Carcinoma
Bayer 18
Testing effectiveness (Phase 2)Looking for participantsNCT06079333
What this trial is testing

NEO- and Adjuvant Targeted Therapy in Braf-mutated Anaplastic Cancer of the Thyroid (NEO-ATACT Study)

Who this might be right for
Anaplastic Thyroid Cancer
Leiden University Medical Center 20
Testing effectiveness (Phase 2)UnknownNCT01118065
What this trial is testing

Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Leiden University Medical Center 42
Early research (Phase 1)WithdrawnNCT02516774
What this trial is testing

A Trial of Adalimumab Combined to Chemotherapy and Radiotherapy in Patients With Anaplastic Thyroid Cancers

Who this might be right for
Anaplastic Thyroid Cancers
Gustave Roussy, Cancer Campus, Grand Paris
Testing effectiveness (Phase 2)Active Not RecruitingNCT04238624
What this trial is testing

Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer

Who this might be right for
Anaplastic Thyroid CancerThyroid CancerBRAF Gene Mutation+1 more
Memorial Sloan Kettering Cancer Center 16
Testing effectiveness (Phase 2)Ended earlyNCT05059470
What this trial is testing

IMRT Followed by Pembrolizumab in the Adjuvant Setting in Anaplastic Cancer of the Thyroid (IMPAACT): Phase II Trial Adjuvant Pembrolizumab After IMRT in ATC

Who this might be right for
Thyroid
M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT02568267
What this trial is testing

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

Who this might be right for
Breast CancerCholangiocarcinomaColorectal Cancer+13 more
Hoffmann-La Roche 534
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06713057
What this trial is testing

Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer

Who this might be right for
Locally Advanced Thyroid Gland CarcinomaThyroid Cancer
West China Hospital 20
Not applicableNot Yet RecruitingNCT07138261
What this trial is testing

Taiwanese Anaplastic Thyroid Cancer Registry

Who this might be right for
Thyroid Carcinoma, Anaplastic
National Health Research Institutes, Taiwan 100
Testing effectiveness (Phase 2)Ended earlyNCT00804830
What this trial is testing

Avastin and Doxorubicin Postoperatively for Patients With Anaplastic Thyroid Cancer

Who this might be right for
Thyroid NeoplasmsCarcinomaThyroid Cancer+1 more
Region Skane 15
Testing effectiveness (Phase 2)Ended earlyNCT03002623
What this trial is testing

CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer

Who this might be right for
Thyroid NeoplasmsPoorly Differentiated and Undifferentiated Thyroid CancerDifferentiated Thyroid Cancer
National Cancer Institute (NCI) 7
Testing effectiveness (Phase 2)Ended earlyNCT00603941
What this trial is testing

CS7017, an Oral PPARγ Agonist, in Combination With Paclitaxel

Who this might be right for
Anaplastic Thyroid Cancer
Daiichi Sankyo 19
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Not applicableEnded earlyNCT00416949
What this trial is testing

Iodine I 131 in Treating Patients With Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Testing effectiveness (Phase 2)Study completedNCT00004089
What this trial is testing

Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer

Who this might be right for
Head and Neck Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT00115739
What this trial is testing

Trial Evaluating Gleevec in Patients With Anaplastic Thyroid Carcinoma

Who this might be right for
Thyroid Cancer
University of Michigan Rogel Cancer Center 11
Early research (Phase 1)Looking for participantsNCT03975231
What this trial is testing

Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer

Who this might be right for
BRAF NP_004324.2:p.V600EBRAF V600K Mutation PresentThyroid Gland Anaplastic Carcinoma
City of Hope Medical Center 6
Testing effectiveness (Phase 2)Looking for participantsNCT06374602
What this trial is testing

Efficacy of Pembrolizumab and Lenvatinib in Patients With Anaplastic Thyroid Cancer

Who this might be right for
Anaplastic Thyroid Cancer
Saint Petersburg State University, Russia 20
Testing effectiveness (Phase 2)UnknownNCT05102292
What this trial is testing

The Efficacy and Safety of HLX208 in Advanced Anaplastic Thyroid Cancer (ATC) With BRAF V600 Mutation

Who this might be right for
Anaplastic Thyroid CancerATC
Shanghai Henlius Biotech 25
Testing effectiveness (Phase 2)Study completedNCT02404441
What this trial is testing

Phase I/II Study of PDR001 in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Sell Lung Cancer (NSCLC)Triple Negative Breast Cancer+2 more
Novartis Pharmaceuticals 319
Load More Results